Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature

Sebastian Rufian-Andujar; Omer Iftikhar; Michael Salinger; Jorge Saucedo; Ted Feldman; Mayra Guerrero

doi:10.1016/j.carrev.2018.02.011

Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature

Sebastian Rufian-Andujar, Omer Iftikhar, Michael Salinger, Jorge Saucedo, Ted Feldman, Mayra Guerrero

Cardiovascular Medicine

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Patients in cardiogenic shock due to severe failure of a mitral bioprosthesis have extremely high risk for repeat standard cardiac surgery. This patient population may benefit the most form the least invasive intervention. We report a successful transseptal mitral valve-in-valve implant performed in a patient in cardiogenic shock due to a flail mitral bioprosthesis requiring bridging intravenous inotropic and intra-aortic balloon pump support.

Original language	English (US)
Pages (from-to)	874-878
Number of pages	5
Journal	Cardiovascular Revascularization Medicine
Volume	19
Issue number	7
DOIs	https://doi.org/10.1016/j.carrev.2018.02.011
State	Published - Oct 1 2018

Keywords

Cardiogenic shock
Mitral regurgitation
Mitral valve-in-valve
Transcatheter mitral valve replacement

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.carrev.2018.02.011

Cite this

Rufian-Andujar, S., Iftikhar, O., Salinger, M., Saucedo, J., Feldman, T., & Guerrero, M. (2018). Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature. Cardiovascular Revascularization Medicine, 19(7), 874-878. https://doi.org/10.1016/j.carrev.2018.02.011

Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature. / Rufian-Andujar, Sebastian; Iftikhar, Omer; Salinger, Michael et al.
In: Cardiovascular Revascularization Medicine, Vol. 19, No. 7, 01.10.2018, p. 874-878.

Research output: Contribution to journal › Review article › peer-review

Rufian-Andujar, S, Iftikhar, O, Salinger, M, Saucedo, J, Feldman, T & Guerrero, M 2018, 'Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature', Cardiovascular Revascularization Medicine, vol. 19, no. 7, pp. 874-878. https://doi.org/10.1016/j.carrev.2018.02.011

Rufian-Andujar S, Iftikhar O, Salinger M, Saucedo J, Feldman T, Guerrero M. Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature. Cardiovascular Revascularization Medicine. 2018 Oct 1;19(7):874-878. doi: 10.1016/j.carrev.2018.02.011

@article{a2e07d5b1a8b4afc853799944b985344,

title = "Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature",

abstract = "Patients in cardiogenic shock due to severe failure of a mitral bioprosthesis have extremely high risk for repeat standard cardiac surgery. This patient population may benefit the most form the least invasive intervention. We report a successful transseptal mitral valve-in-valve implant performed in a patient in cardiogenic shock due to a flail mitral bioprosthesis requiring bridging intravenous inotropic and intra-aortic balloon pump support.",

keywords = "Cardiogenic shock, Mitral regurgitation, Mitral valve-in-valve, Transcatheter mitral valve replacement",

author = "Sebastian Rufian-Andujar and Omer Iftikhar and Michael Salinger and Jorge Saucedo and Ted Feldman and Mayra Guerrero",

note = "Funding Information: Funding Sources : The manuscript was not supported by external funding. Funding Information: Disclosures: Dr. Guerrero has served as a proctor and received research grant support from Edwards Lifesciences. Dr. Salinger has served as a proctor for Edwards Lifesciences and Boston Scientific. Dr. Feldman has served as a consultant and received research grant support from Abbott Vascular, Boston Scientific and Edwards Lifesciences. Publisher Copyright: {\textcopyright} 2018",

year = "2018",

month = oct,

day = "1",

doi = "10.1016/j.carrev.2018.02.011",

language = "English (US)",

volume = "19",

pages = "874--878",

journal = "Cardiovascular Revascularization Medicine",

issn = "1553-8389",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock

T2 - Case report and review of the literature

AU - Rufian-Andujar, Sebastian

AU - Iftikhar, Omer

AU - Salinger, Michael

AU - Saucedo, Jorge

AU - Feldman, Ted

AU - Guerrero, Mayra

N1 - Funding Information: Funding Sources : The manuscript was not supported by external funding. Funding Information: Disclosures: Dr. Guerrero has served as a proctor and received research grant support from Edwards Lifesciences. Dr. Salinger has served as a proctor for Edwards Lifesciences and Boston Scientific. Dr. Feldman has served as a consultant and received research grant support from Abbott Vascular, Boston Scientific and Edwards Lifesciences. Publisher Copyright: © 2018

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Patients in cardiogenic shock due to severe failure of a mitral bioprosthesis have extremely high risk for repeat standard cardiac surgery. This patient population may benefit the most form the least invasive intervention. We report a successful transseptal mitral valve-in-valve implant performed in a patient in cardiogenic shock due to a flail mitral bioprosthesis requiring bridging intravenous inotropic and intra-aortic balloon pump support.

AB - Patients in cardiogenic shock due to severe failure of a mitral bioprosthesis have extremely high risk for repeat standard cardiac surgery. This patient population may benefit the most form the least invasive intervention. We report a successful transseptal mitral valve-in-valve implant performed in a patient in cardiogenic shock due to a flail mitral bioprosthesis requiring bridging intravenous inotropic and intra-aortic balloon pump support.

KW - Cardiogenic shock

KW - Mitral regurgitation

KW - Mitral valve-in-valve

KW - Transcatheter mitral valve replacement

UR - http://www.scopus.com/inward/record.url?scp=85044930907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044930907&partnerID=8YFLogxK

U2 - 10.1016/j.carrev.2018.02.011

DO - 10.1016/j.carrev.2018.02.011

M3 - Review article

C2 - 29636301

AN - SCOPUS:85044930907

SN - 1553-8389

VL - 19

SP - 874

EP - 878

JO - Cardiovascular Revascularization Medicine

JF - Cardiovascular Revascularization Medicine

IS - 7

ER -

Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this